| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.558 | 6.733 | 18.680 | 23.427 | 81.763 | 117.927 |
| Total Income - EUR | - | - | - | - | 2.558 | 6.734 | 18.680 | 23.428 | 81.765 | 117.929 |
| Total Expenses - EUR | - | - | - | - | 35 | 1.385 | 1.557 | 10.922 | 14.861 | 42.097 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.523 | 5.348 | 17.124 | 12.506 | 66.904 | 75.831 |
| Net Profit/Loss - EUR | - | - | - | - | 2.446 | 5.163 | 16.571 | 12.124 | 66.102 | 72.364 |
| Employees | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Quarc Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 27 | 0 | 0 | 12.170 | 7.853 | 87.503 |
| Current Assets | - | - | - | - | 2.602 | 5.271 | 17.972 | 12.308 | 75.993 | 60.877 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 1.202 | 2.972 | 2.140 | 44.121 | 38.979 |
| Cash | - | - | - | - | 2.602 | 4.069 | 15.000 | 10.167 | 31.872 | 21.898 |
| Shareholders Funds | - | - | - | - | 2.488 | 5.213 | 16.619 | 19.731 | 66.151 | 72.413 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 140 | 87 | 1.425 | 4.804 | 17.861 | 76.314 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Quarc Med S.r.l.